Adult Immunization

Study description

We will implement a multicomponent approach consisting of clinical decision support, standing orders, improved documentation, and provider education, with the aim of increasing pneumococcal and influenza vaccination rates in at-risk adults aged 18+. At-risk is defined as all adults aged 65 and older and adults aged 19-64 who have certain risk factors. It is hypothesized that the intervention activities will lead to increased vaccination rates through improvements to the care delivery system at the study site.

Methods

A multi-component intervention targeting clinicians and consisting of clinical decision support, standing orders, audit and feedback, improved documentation, and focused clinician education. The intervention will be evaluated by analyzing data extracted from the study site EHR at regular intervals, as well as interviews with participating clinicians.

Specific Aims

  1. Achieve at least a 20% improvement in immunization rates as compared to the baseline for pneumococcal and influenza immunizations in adult patients 65 years of age or older within the first 12 months following implementation of the intervention;
  2. Achieve at least a 20% improvement in immunization rates as compared to the baseline for pneumococcal and influenza immunizations in high-risk adult patients 19-64 years of age within the first 12 months following implementation of the intervention.

Timeline

March 1st, 2015 - October 31st, 2016

Status

This study is in the pre-intervention phase.

Key findings and publications

Please check back later for key findings and publications.

Contact Information

Natalia Loskutova, MD PhD
Director of Evaluation
AAFP National Research Network
(800) 274-2237, ext. 3186
nloskutova@aafp.org

Craig Smail, MA MSc
Research Project Manager
AAFP National Research Network
(800) 274-2237, ext. 3185
csmail@aafp.org


This study is funded by an unrestricted grant from Merck